Cart (0 Items)
Your cart is currently empty.
View ProductsSize | 100ug, 1MG |
---|---|
Isotype | IgG1, kappa |
Brand | ProteoGenix |
Product type | Primary Antibodies |
Clonality | Monoclonal Antibody |
Expression system | Mammalian cells |
Applications | Elisa, WB |
Product name | Pertuzumab Biosimilar - Anti-ERBB2, EGFR2, CD340 mAb - Research Grade |
---|---|
Source | CAS 380610-27-5 |
Species | Humanized |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Aliases /Synonyms | Pertuzumab,OMNITARG,rhuMAB 2C4,ERBB2, EGFR2, CD340,anti-ERBB2, EGFR2, CD340 |
Reference | PX-TA1058 |
Note | For research use only. Not suitable for human use. |
Isotype | IgG1-kappa |
Clonality | Monoclonal Antibody |
Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (subdomain II) of human epidermal growth factor receptor 2 protein (HER2). It was first used with docetaxel and another HER2-targeting monoclonal antibody trastuzumab to treat metastatic HER2-positive breast cancer. Since then, its indications have been expanded to be used as both neoadjuvant therapy and adjuvant therapy for the treatment of HER2-positive breast cancer with a high risk of recurrence.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.